🔗 Share this article

Chancellor Reeves has stated she is planning "focused measures to deal with cost of living pressures" in next month's financial statement.

Speaking to media outlets, she stated that reducing price rises is a joint responsibility of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the highest among the G7 industrialized countries this calendar year and next.

Potential Utility Bill Interventions

Reports indicate the government could take action to lower utility costs, for instance by cutting the present 5% rate of value-added tax charged on energy.

A further possibility is to reduce some of the government charges currently added to household expenses.

Fiscal Limitations and Analyst Predictions

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for such measures.

The consensus from most economists is that the Chancellor will have to introduce tax increases or expenditure reductions in order to meet her self-imposed borrowing rules.

Previously on Thursday, analysis showed there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the more modest range of forecasts.

"There's a joint responsibility between the central bank and the administration to bear down further on some of the causes of price increases," Reeves stated to the BBC in Washington, at the conferences of the International Monetary Fund and World Bank.

Tax Pledges and International Concerns

While a great deal of the focus has been on probable tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her pledge to election pledges not to raise rates on earnings tax, VAT or National Insurance.

She blamed an "unpredictable world" with increasing geopolitical and trade tensions for the fiscal tax moves, probably to be focused on those "wealthiest."

International Economic Tensions

Referring to concerns about the United Kingdom's commercial links with the Asian nation she said: "Our security interests always are paramount."

Recent declaration by Chinese authorities to strengthen trade restrictions on rare earths and other resources that are crucial for advanced tech production led US President Donald Trump to propose an extra 100% import tax on goods from the Asian country, raising the risk of an all-out commercial conflict between the two economic giants.

The American finance chief described the Chinese decision "commercial pressure" and "a international production power grab."

Questioned on accepting the American proposal to participate in its dispute with China, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "bad for the international commerce and creates further challenges."

"In my view there are sectors where we should confront China, but there are also significant opportunities to export to China's economy, including banking sector and other areas of the economic system. We've got to achieve that balance correct."

The Treasury chief also confirmed she was working with other major economies "on our own essential resources plan, so that we are reduced dependence."

Health Service Medicine Pricing and Funding

Reeves also acknowledged that the price the NHS pays for medicines could rise as a consequence of current discussions with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or canceling projects in the UK, with some attributing the modest returns they are getting.

Recently, the Science Minister said the price the NHS spends on drugs would have to increase to stop companies and drug research funding departing from the United Kingdom.

Reeves stated to media: "We have seen due to the pricing regime, that drug testing, innovative medicines have not been offered in the United Kingdom in the manner that they are in other European countries."

"We want to guarantee that people getting care from the NHS are can receive the finest critical drugs in the world. And so we are reviewing this situation, and... seeking to attract additional capital into the UK."